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LETTER TO THE EDITOR Open Access
Respond to the letter to the editor by Van’t
Hul et al. regarding the published
manuscript “can do, don’t do” are not the
lazy ones: a longitudinal study on physical
functioning in patients with COPD” by Sievi
et al.(1)
Noriane A. Sievi* , Malcolm Kohler and Christian F. Clarenbach
We want to thank the authors for the letter and their interest
in our study [1]. They raise several important points.
The relationship between physical activity (PA) and
physical capacity (PC) in patients with chronic obstruct-
ive pulmonary disease (COPD) is controversially dis-
cussed, although the negative impact of physical
inactivity in these patients is a stable finding in the lit-
erature [2, 3]. Therefore, a concept that includes PA and
PC in relation to each other, such as the one developed
by Koolen et al. [4], could provide a very useful and
practicable tool to identify clinical characteristics re-
sponsible for the impairments observed in PA and/or
PC. Such a concept may also allow improving the effect
of physical functioning interventions. We applied this
concept in our COPD cohort to challenge its robustness
and stability. We feel that drawing definitive conclusions
regarding its usability will require more cohorts than just
two. Furthermore, the additional application of the PC-
PA concept on longitudinal data was possibly not the
intention of the inventors. Due to the longitudinal data
we could also assess if patients mainly remain in a PC-
PA quadrant over several years or if there are annual
quadrant changes. Changes in PC and/or PA are
frequently observed in COPD patients. Therefore, the
concept was also tested for its ability to reflect these
changes. We are aware of the fact that changes in PC-
PA quadrants can be due to various changes of physical
functioning, as Van’t Hul et al. mention. We are con-
vinced that due to the usual natural history of COPD, all
patients will eventually approach the “can’t do, don’t do”
situation and the quadrants are located on this downward
slope starting with “can do, do do”. Based on the results
from our previous study showing a decline in PA while
PC remained stable, we conclude that decrease in PC oc-
curs time delayed [5]. That is why we summarized all sub-
jects with either decreasing PA or PC or both in one
group. Since there are no studies that observed COPD
patients long enough to proof this hypothesis, there is the
possibility that our approach may be inappropriate.
Van’t Hul et al. correctly state that we used a different
equation for the percentage of prediction of the 6-min
walking distance (6MWD) and that methodology is always
a key factor for comparability of different studies and we
should have considered this. However, if the use of
another, also widely used equation, generates completely
different results in quadrant phenotypes, it remains ques-
tionable, if the concept, in its present form, is able to
describe the underlying mechanisms categorizing the
patients into the four PC-PA quadrants. The same is true
for differences in primary versus secondary care or disease
severity, which was indeed slightly different in our cohort.
We agree that Koolen et al. [4] never used the term
“lazy” to characterize a subgroup of COPD patients.
Instead, they describe the “can do, don’t do” quadrant as
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persons who have the ability to be active, but “just don’t
do it” and state that promoting PA in this subgroup is not
an “easy task”. To disentangle behavioral and physical aspects
of inactivity will be the challenge for further research.
Authors’ contributions
The authors read and approved the final manuscript.
Competing interests
CFC received advisory fees from Roche, Novartis, Boehringer, GSK, Astra
Zeneca, Sanofi, Vifor and Mundipharma within the last 36 months. MK
reports advisory fees from Novartis, Bayer, GSK, Mundipharma, Astra Zeneca
and Boehringer Ingelheim. NAS has no competing interests.
Received: 14 April 2020 Accepted: 27 April 2020
References
1. Sievi NA, Brack T, Brutsche MH, Frey M, Irani S, Leuppi JD, et al. “Can do,
don’t do” are not the lazy ones: a longitudinal study on physical
functioning in patients with COPD. Respir Res. 2020;21(1):27.
2. Waschki B, Kirsten A, Holz O, Muller KC, Meyer T, Watz H, et al. Physical
activity is the strongest predictor of all-cause mortality in patients with
COPD: a prospective cohort study. Chest. 2011;140(2):331–42.
3. Puhan MA, Siebeling L, Zoller M, Muggensturm P, ter Riet G. Simple
functional performance tests and mortality in COPD. Eur Respir J. 2013;42(4):
956–63.
4. Koolen EH, van Hees HW, van Lummel RC, Dekhuijzen R, Djamin RS, Spruit
MA, et al. “Can do” versus “do do”: A Novel Concept to Better Understand
Physical Functioning in Patients with Chronic Obstructive Pulmonary
Disease. J Clin Med. 2019;8(3):340.
5. Sievi NA, Brack T, Brutsche MH, Frey M, Irani S, Leuppi JD, et al. Physical
activity declines in COPD while exercise capacity remains stable: a
longitudinal study over 5 years. Respir Med. 2018;141:1–6.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Sievi et al. Respiratory Research          (2020) 21:114 Page 2 of 2
